Allergic Rhinitis Global Clinical Trials Review, H2, 2019
December 2019
897
About the Report
About the Report
Allergic Rhinitis Global Clinical Trials Review, H2, 2019
Summary
GlobalData's clinical trial report, Allergic Rhinitis Global Clinical Trials Review, H2, 2019 provides an overview of Allergic Rhinitis clinical trials scenario. This report provides top line data relating to the clinical trials on Allergic Rhinitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Products
Companies
GlaxoSmithKline Plc
Merck & Co Inc
UCB SA
Sanofi
Novartis AG
The Lundbeck Foundation
AstraZeneca Plc
Mylan NV
Teva Pharmaceutical Industries Ltd
Dr. Reddy's Laboratories Ltd
Table of Contents
Table of Contents
Table of Contents
List of Tables 4
List of Figures 5
Report Guidance 6
GlobalData Clinical Trials Report Coverage 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by G7 Countries: Proportion of Allergic Rhinitis to Respiratory Clinical Trials 17
Clinical Trials by Phase in G7 Countries 18
Clinical Trials in G7 Countries by Trial Status 19
Clinical Trials by E7 Countries: Proportion of Allergic Rhinitis to Respiratory Clinical Trials 21
Clinical Trials by Phase in E7 Countries 22
Clinical Trials in E7 Countries by Trial Status 23
Clinical Trials by Phase 25
In Progress Trials by Phase 26
Clinical Trials by Trial Status 27
Clinical Trials by End Point Status 29
Subjects Recruited Over a Period of Time 30
Clinical Trials by Sponsor Type 31
Prominent Sponsors 32
Top Companies Participating in Allergic Rhinitis Therapeutics Clinical Trials 34
Prominent Drugs 36
Latest Clinical Trials News on Allergic Rhinitis 37
Nov 26, 2019: Marinomed Biotech AG: Detailed clinical data show rapid onset of action of Budesolv to alleviate hay fever 37
Nov 08, 2019: ALK to present new phase 3 data demonstrating the efficacy and safety of Ragwitek (short ragweed pollen allergen extract tablet for sublingual use 12 Amb a 1-U) Sublingual Allergy Immunotherapy (SLIT)-Tablets in pediatric patients at ACAAI 2019 Annual Scientific Meeting 37
Clinical Trial Profile Snapshots 39
Appendix 926
Abbreviations 926
Definitions 926
Research Methodology 927
Secondary Research 927
About GlobalData 928
Contact Us 928
Source 929
List of Figure
List of Figures
Allergic Rhinitis Therapeutics, Global, Clinical Trials by Region (%), 2019* 8
Allergic Rhinitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9
Allergic Rhinitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11
Allergic Rhinitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 12
Allergic Rhinitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 13
Allergic Rhinitis Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 14
Allergic Rhinitis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2019* 15
Allergic Rhinitis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2019* 16
Proportion of Allergic Rhinitis to Respiratory Clinical Trials, G7 Countries (%), 2019* 17
Allergic Rhinitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 18
Allergic Rhinitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 19
Proportion of Allergic Rhinitis to Respiratory Clinical Trials, E7 Countries (%), 2019* 21
Allergic Rhinitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 22
Allergic Rhinitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 23
Allergic Rhinitis Therapeutics, Global, Clinical Trials by Phase (%), 2019* 25
Allergic Rhinitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 26
Allergic Rhinitis Therapeutics, Global, Clinical Trials by Trial Status, 2019* 27
Allergic Rhinitis Therapeutics Clinical Trials, Global, by End Point Status, 2019* 29
Allergic Rhinitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 30
Allergic Rhinitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 31
Allergic Rhinitis Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 32
Allergic Rhinitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 34
Allergic Rhinitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 36
GlobalData Methodology 927
List of Table
List of Tables
Allergic Rhinitis Therapeutics, Global, Clinical Trials by Region, 2019* 8
Allergic Rhinitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 10
Allergic Rhinitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11
Allergic Rhinitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 12
Allergic Rhinitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 13
Allergic Rhinitis Therapeutics Clinical Trials, North America, Top Countries, 2019* 14
Allergic Rhinitis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2019* 15
Allergic Rhinitis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2019* 16
Proportion of Allergic Rhinitis to Respiratory Clinical Trials, G7 Countries (%), 2019* 17
Allergic Rhinitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 18
Allergic Rhinitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 20
Proportion of Allergic Rhinitis to Respiratory Clinical Trials, E7 Countries (%), 2019* 21
Allergic Rhinitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 22
Allergic Rhinitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 24
Allergic Rhinitis Therapeutics, Global, Clinical Trials by Phase, 2019* 25
Allergic Rhinitis Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 26
Allergic Rhinitis Therapeutics, Global, Clinical Trials by Trial Status, 2019* 28
Allergic Rhinitis Therapeutics Clinical Trials, Global, by End Point Status, 2019* 29
Allergic Rhinitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 30
Allergic Rhinitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 31
Allergic Rhinitis Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 33
Allergic Rhinitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 35
Allergic Rhinitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 36
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.